Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and...
read more
Tuesday, October 06, 2020
Henry Schein has implemented TraceLink’s verification router service (VRS) solution.
read more
Thursday, February 24, 2022
Contract development and manufacturing organisation Micro-Sphere has invested more than €1.5 million at its plant in Switzerland to expand its offering in encapsulation for inhalation products.
read more
ScienceMedia announced their partnership with Apex Mobile Clinical Research (AMCR), a provider of decentralized clinical trial solutions and services to underserved communities. AMCR will be using ScienceMedia's protocol compliance management ...
read more
Heat Biologics, Inc. is changing the name of the company to NightHawk Biosciences, Inc., effective May 3, 2022, to better reflect the Company’s evolution, including expansion of its therapeutic pipeline, the vertical integration of capabilities from ...
read more
Icosagen, a CRDMO with expertise in innovative antibody research and production, announced a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC), a translational drug discovery organization tapping on a broad network in ...
read more
Ligand announces the acquisition of economic rights to SB206 from Novan.
read more
Eli Lilly and Company has announced that John C. Lechleiter, Ph.D., chairman, president and chief executive officer, will retire as president and CEO and from the company effective December 31, 2016.
read more
Wednesday, September 21, 2022
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, announced that Merck, known as MSD outside the ...
read more
DSP Clinical has announced a new co-monitoring service that provides flexible monitoring support to help clinical trials meet study timelines.
read more
Dr. Havranek-Kosicek, previously Director of Finance and Control for the DSM Pharma Chemicals business unit of DSM Pharmaceutical Products, the pharmaceutical contract manufacturing and technology organization of Royal DSM N.V. (NYSE, Euronext: DSM ...
read more
Ligand Pharmaceuticals has entered into a worldwide license agreement with Gilead Sciences, Inc. Under the license, Gilead will be able to use the OmniRat®, OmniMouse® and OmniFlic® platforms to discover fully human mono- and bispecific antibodies to...
read more
Wednesday, January 04, 2017
MilliporeSigma has acquired BioControl Systems Inc., a provider of food safety testing. The acquisition opens growth opportunities for MilliporeSigma in the food and beverage space, particularly in the U.S. Confidentiality has been agreed on the ...
read more
Charles River has completed the previously announced acquisition of Cognate BioServices for approximately $875 million.
read more
Astorg and International Chemical Investors Group (ICIG) have signed a binding agreement whereby Astorg will acquire CordenPharm from ICIG. As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg.
read more